PET imaging of zirconium-89 labelled cetuximab : a phase I trial in patients with head and neck and lung cancer
- Author
- Judith van Loon, Aniek JG Even, Hugo JWL Aerts, Michel Öllers, Frank Hoebers, Wouter van Elmpt, Ludwig Dubois, Anne-Marie C Dingemans, Roy I Lalisang, Pascal Kempers, Boudewijn Brans (UGent) , Véronique Winnepenninckx, Ernst-Jan Speel, Eric Thunnissen, Kim M Smits, Ronald Boellaard, Danielle J Vugts, Dirk De Ruysscher and Philippe Lambin
- Organization
- Keywords
- Zr-89-cetuximab, EGFR, Immuno-PET, Phase I trial, GROWTH-FACTOR RECEPTOR, MONOCLONAL-ANTIBODIES, PLUS CETUXIMAB, 1ST-LINE CHEMOTHERAPY, EGFR-INHIBITION, IMMUNO-PET, EXPRESSION, RADIOTHERAPY, CARCINOMA, SURVIVAL
Citation
Please use this url to cite or link to this publication: http://hdl.handle.net/1854/LU-8510862
- MLA
- van Loon, Judith, et al. “PET Imaging of Zirconium-89 Labelled Cetuximab : A Phase I Trial in Patients with Head and Neck and Lung Cancer.” RADIOTHERAPY AND ONCOLOGY, vol. 122, no. 2, 2016, pp. 267–73, doi:10.1016/j.radonc.2016.11.020.
- APA
- van Loon, J., Even, A. J., Aerts, H. J., Öllers, M., Hoebers, F., van Elmpt, W., … Lambin, P. (2016). PET imaging of zirconium-89 labelled cetuximab : a phase I trial in patients with head and neck and lung cancer. RADIOTHERAPY AND ONCOLOGY, 122(2), 267–273. https://doi.org/10.1016/j.radonc.2016.11.020
- Chicago author-date
- Loon, Judith van, Aniek JG Even, Hugo JWL Aerts, Michel Öllers, Frank Hoebers, Wouter van Elmpt, Ludwig Dubois, et al. 2016. “PET Imaging of Zirconium-89 Labelled Cetuximab : A Phase I Trial in Patients with Head and Neck and Lung Cancer.” RADIOTHERAPY AND ONCOLOGY 122 (2): 267–73. https://doi.org/10.1016/j.radonc.2016.11.020.
- Chicago author-date (all authors)
- van Loon, Judith, Aniek JG Even, Hugo JWL Aerts, Michel Öllers, Frank Hoebers, Wouter van Elmpt, Ludwig Dubois, Anne-Marie C Dingemans, Roy I Lalisang, Pascal Kempers, Boudewijn Brans, Véronique Winnepenninckx, Ernst-Jan Speel, Eric Thunnissen, Kim M Smits, Ronald Boellaard, Danielle J Vugts, Dirk De Ruysscher, and Philippe Lambin. 2016. “PET Imaging of Zirconium-89 Labelled Cetuximab : A Phase I Trial in Patients with Head and Neck and Lung Cancer.” RADIOTHERAPY AND ONCOLOGY 122 (2): 267–273. doi:10.1016/j.radonc.2016.11.020.
- Vancouver
- 1.van Loon J, Even AJ, Aerts HJ, Öllers M, Hoebers F, van Elmpt W, et al. PET imaging of zirconium-89 labelled cetuximab : a phase I trial in patients with head and neck and lung cancer. RADIOTHERAPY AND ONCOLOGY. 2016;122(2):267–73.
- IEEE
- [1]J. van Loon et al., “PET imaging of zirconium-89 labelled cetuximab : a phase I trial in patients with head and neck and lung cancer,” RADIOTHERAPY AND ONCOLOGY, vol. 122, no. 2, pp. 267–273, 2016.
@article{8510862,
author = {{van Loon, Judith and Even, Aniek JG and Aerts, Hugo JWL and Öllers, Michel and Hoebers, Frank and van Elmpt, Wouter and Dubois, Ludwig and Dingemans, Anne-Marie C and Lalisang, Roy I and Kempers, Pascal and Brans, Boudewijn and Winnepenninckx, Véronique and Speel, Ernst-Jan and Thunnissen, Eric and Smits, Kim M and Boellaard, Ronald and Vugts, Danielle J and De Ruysscher, Dirk and Lambin, Philippe}},
issn = {{0167-8140}},
journal = {{RADIOTHERAPY AND ONCOLOGY}},
keywords = {{Zr-89-cetuximab,EGFR,Immuno-PET,Phase I trial,GROWTH-FACTOR RECEPTOR,MONOCLONAL-ANTIBODIES,PLUS CETUXIMAB,1ST-LINE CHEMOTHERAPY,EGFR-INHIBITION,IMMUNO-PET,EXPRESSION,RADIOTHERAPY,CARCINOMA,SURVIVAL}},
language = {{eng}},
number = {{2}},
pages = {{267--273}},
title = {{PET imaging of zirconium-89 labelled cetuximab : a phase I trial in patients with head and neck and lung cancer}},
url = {{http://doi.org/10.1016/j.radonc.2016.11.020}},
volume = {{122}},
year = {{2016}},
}
- Altmetric
- View in Altmetric
- Web of Science
- Times cited: